1.Beall MH, J PHMV, Gemert MJCV, Ross MG. Regulation of Amniotic Fluid Volume. Placenta. 2007;28(8):824–832.
2.Ounpraseuth ST, Magann EF, Spencer HJ, Rabie NZ, Sandlin AT. Normal amniotic fluid volume across gestation: Comparison of statistical approaches in 1190 normal amniotic fluid volumes. J Obstet Gynaecol Res. 2017;56(4 Pt 1):11–11.
3.Lei H, Wen SW. Normal amniotic fluid index by gestational week in a Chinese population. Central-South China Fetal Growth Study Group. Obstet Gynecol. 1998;92(2):237–240.
4.Gadd RL. The volume of the liquor amnii in normal and abnormal pregnancies. Journal of Obstetrics & Gynaecology of the British Commonwealth. 2010;73(1):11–22.
5.Morris JM, Thompson K, Smithey J, Gaffney G, Cooke I, Chamberlain P, Hope P, Altman D, Mackenzie IZ. The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study. Bjog. 2003;110(11):989–994.
6.Magann EF, Sanderson M, Martin JN, Chauhan S. The amniotic fluid index, single deepest pocket, and two-diameter pocket in normal human pregnancy. American Journal of Obstetrics & Gynecology. 2000;182(6):1581–1588.
7.Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, Twickler DM, Ramus RM, Leveno KJ. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation ☆. American Journal of Obstetrics & Gynecology. 2000;182(4):909–912.
8.Asnafi N, Bouzari Z, Mohammadnetadj M. Oligohydramnios and Pregnancy Outcome: Ten-Years Review. 2015.
9.Tarannum K, Hamid AAA, Irfan H, Shankar GR, Md A, Parwez. Oligohydramnios and Fetal Outcome: A Review. Med Phoenix. 1(1):23–30.
10.Huarte M. The emerging role of lncRNAs in cancer. Nature Medicine. 2015;21(11):1253.
11.Li N, Ponnusamy M, Li MP, Wang K, Li PF. The Role of MicroRNA and LncRNA-MicroRNA Interactions in Regulating Ischemic Heart Disease. Journal of Cardiovascular Pharmacology & Therapeutics. 2016;22(2).
12.El AH, Doevendans PA, Sluijter JP. Long non-coding RNAs in heart failure: an obvious lnc. Annals of Translational Medicine. 2016;4(9):182.
13.Wang J, Wei F, Zhou H. Advances of lncRNA in autoimmune diseases. Frontiers in Laboratory Medicine. 2018;2(2):79–82.
14.Machtinger R, Zhong J, Mansur A, Adir M, Racowsky C, Hauser R, Brennan K, Karlsson O, Baccarelli AA. Placental lncRNA Expression Is Associated With Prenatal Phthalate Exposure. Toxicological Sciences An Official Journal of the Society of Toxicology. 2018;163(1):116.
15.Zhang P, Chen X, Zhang Y, Xu T, Li N, Tao J, Xu Z. LncRNA uc003fir promotes CCL5 expression and negatively affects proliferation and migration of trophoblast cells in preeclampsia. Pregnancy Hypertension ER -. 2018;90–96.
16.Uguz F, Gezginc K, Korucu D, Sayal B. Are Major Depression and Generalized Anxiety Disorder Associated with Oligohydramnios in Pregnant Women? a Case-control Study. Perspectives in Psychiatric Care. 2015;30(4):310–310.
17.Akram W. The role of resistance index in fetal renal artery in causing oligohydramnios among overdue pregnant women. Mustansiriya Medical Journal; Vol 13 No 1 (2014): Mustansiriyah Medical Journal. 2018.
18.Holmes RP, Stone PR. Severe oligohydramnios induced by cyclooxygenase–2 inhibitor nimesulide. Obstetrics & Gynecology. 2000;96(5):810–811.
19.Scherneck S, Schöpa FL, Entezami M, Kayser A, Weber-Schoendorfer C, Schaefer C. Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure. Reproductive Toxicology. 2015;58(61–64.
20.Wang X, Shi X, Guo D, Pan Q, Li Y, Tong F. Expression and significance of aquaporin 11 in placenta and fetal membranes of term parturient with oligohydramnios. Journal of Xi’an Jiaotong University(Medical Sciences). 2017;38(5):715–719.
21.Zhu XQ, Jiang SS, Zhu XJ, Zou SW, Wang YH, Hu YC. Expression of Aquaporin 1 and Aquaporin 3 in Fetal Membranes and Placenta in Human Term Pregnancies with Oligohydramnios. Placenta. 2009;30(8):670–676.
22.Shan-Shan J, Xue-Jie Z, Sheng-Di D, Jing-Jing W, Ling-Ling J, Wen-Xiao J, Xue-Qiong Z. Expression and localization of aquaporins 8 and 9 in term placenta with oligohydramnios. Reproductive Sciences. 2012;19(12):1276–1284.
23.Zhang RF. The Correlation between The Expression of Survivin, Caspase–3 andAQP1 in Fetal Membranes and The Human Oligohydramnios. Chinese Journal of Medicinal Guide. 2012.
24.Shi FH. Histochemistry analysis of AKP –PAS reaction on amniotic membrane and placenta with oligohydramnios in full month pregnancy. Journal of Taishan Medical College. 2011.
25.Dan FU, Wang P. Changes of Cu,Zn and Mg in intrahepatic cholestasis of pregnance,fetal growth restriction and oligohydramnios. Journal of Clinical Medicine in Practice. 2010.
26.Enquobahrie DA, Hensley M, Qiu C, Abetew DF, Hevner K, Tadesse MG, Williams MA. Candidate Gene and MicroRNA Expression in Fetal Membranes and Preterm Delivery Risk. Reproductive Sciences. 2016;23(6):731.
27.Ramkumar M, Jossimara P, Tariq Ali S, Saade GR, Istvan B. Expression of 8-oxoguanine glycosylase in human fetal membranes. American Journal of Reproductive Immunology. 2014;72(1):75–84.
28.Michelle B-F, Marie-Josèphe L, Olivier D, Pierrette R, Audrey C, Hong Q, Guy G, Michel A F, Gilles C. Differential expression of the enzymatic system controlling synthesis, metabolism, and transport of PGF2 alpha in human fetal membranes. Biology of Reproduction. 2001;83(1):155–162.
29.Pereyra S, Bertoni B, Sosa C, Sapiro R. Transcriptomic analysis of fetal membranes reveals pathways involved in preterm birth. bioRxiv. 2018;358945.
30.Zhai Q, Liang Z, Zhao C, Wan J, Yu Z, Xin G, Jie Q, Jing C, Lu R. Identification of miR–508–3p and miR–509–3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochemical & Biophysical Research Communications. 2012;419(4):621–626.
31.Xu X, Chen R, Li Z, Huang N, Wu X, Li S, Li Y, Wu S. MicroRNA–490–3p inhibits colorectal cancer metastasis by targeting TGFβR1. Bmc Cancer. 2015;15(1):1023.
32.Wu SG, Huang YJ, Bao B, Wu LM, Dong J, Liu XH, Li ZH, Wang XY, Wang L, Chen BJ. miR–508–5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma. Neoplasma. 2017;64(1):40–47.
33.Li M, Liu Q, Lei J, Wang X, Chen X, Ding Y. MiR–362–3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1. Biochemical & Biophysical Research Communications. 2017;493(1).
34.Qiu J, Hao Y, Huang S, Ma Y, Li X, Li D, Mao Y. MiR–557 works as a tumor suppressor in human lung cancers by negatively regulating LEF1 expression. Tumour Biology the Journal of the International Society for Oncodevelopmental Biology & Medicine. 2017;39(6):1010428317709467.
35.Zhang Y, Xu G, Liu G, Ye Y, Zhang C, Fan C, Wang H, Cai H, Xiao R, Huang Z. miR–411–5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. Biochemical & Biophysical Research Communications. 2016;476(4):607–613.
36.Wei Y, Sun Q, Zhao L, Wu J, Chen X, Wang Y, Zang W, Zhao G. LncRNA UCA1-miR–507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma. Medical Oncology. 2016;33(8):1–9.
37.Huang C, Geng J, Wei X, Zhang R, Jiang S. MiR–144–3p regulates osteogenic differentiation and proliferation of murine mesenchymal stem cells by specifically targeting Smad4. Febs Letters. 2016;590(6).
38.Sun H, Zhang Z, Huang Z, Mao G, Yu B, Zhang C, Fu M. Effect of chondrogenesis related miR–4287 on expression of aggrecanase–1 in human chondrocytes. Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery. 2017;31(12):1468–1473.
39.Shah VS, Ernst S, Tang XX, Karp PH, Parker CP, Ostedgaard LS, Welsh MJ. Relationships among CFTR expression, HCO3- secretion, and host defense may inform gene- and cell-based cystic fibrosis therapies. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(19):5382.
40.Schoor LWEV, Verkade HJ, Folkert K, Jonker JW. New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition. Expert Opinion on Drug Metabolism & Toxicology. 2015;11(2):273–293.
41.Haywood S, Boursnell M, Loughran MJ, Trafford J, Isherwood D, Liu X, Olohan L, Carter SD. Copper toxicosis in non-COMMD1 Bedlington terriers is associated with metal transport gene ABCA12. Journal of Trace Elements in Medicine & Biology. 2016;35(83–89.
42.Akiyama M, Sugiyama NYK, McMillan JR, Goto M, Arita K, Tsuji AY, Tabata N, Matsuoka K, Sasaki R, Sawamura D. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. Journal of Clinical Investigation. 2005;115(7):1777–1784.
43.Meng T, Ren Q, Wang JM, Shi H, Zhang ST, Liu MT. Association between COL9A2 Gln326Arg mutations and the development of intervertebral disc disease in a Chinese population. Genetics & Molecular Research Gmr. 2016;15(4).
44.Bianchi DW, LeShane ES, Cowan JM. Large amounts of cell-free fetal DNA are present in amniotic fluid. Clin Chem. 2001;47(10):1867–1869.
45.Larrabee PB, Johnson KL, Lai C, Ordovas J, Cowan JM, Tantravahi U, Bianchi DW. Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA. 2005;293(7):836–842.
46.Hui L, Bianchi DW. Cell-free fetal nucleic acids in amniotic fluid. Hum Reprod Update. 2011;17(3):362–371.